Activity of Biocidin® against microbial biofilms

Clicks: 1
ID: 310043
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #281 of 490 articles by views in Frontiers in surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 490 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Biofilms – microbial communities – are present throughout the environment and interact with humans as part of the resident microbiome or when causing infection and disease. Antibiotics are commonly used to treat bacterial infections, including the ones due to biofilms. However, antimicrobial tolerance and resistance are common traits of these microbial communities. Resistance to antimicrobials is now widely found and the search for alternative treatments, such as plant/herbal extracts, essential oils, and honey, is on the rise. Here, we investigated the effect of Biocidin®, a botanical supplement on biofilms of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Candida albicans. A single (bolus) dose of Biocidin® resulted in a significant decrease (> 2 Log) of biofilm and planktonic populations, while a 24-hour continuous dose of 25% and 50% Biocidin® led to a typical biphasic killing curve resulting in biofilm eradication of P. aeruginosa, S. aureus, and E. coli, in the latter concentration. Exposure to sub-inhibitory concentrations of Biocidin® did not affect biofilm viability. Results from this work have implications for the use of Biocidin® as a treatment of biofilm infections and as a supplement in natural medicine.
Reference Key
imported_1768918433_696f8da1dd578 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Marques, Claudia NH
Journal Frontiers in surgery
Year Year not found
DOI
10.3389/frabi.2025.1692653
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.